Known central nervous system (CNS) lymphoma
Medically apparent central nervous system lymphoma or leptomeningeal disease
Central nervous system lymphoma or leptomeningeal infiltration
History of central nervous system lymphoma (either primary or metastatic).
Central nervous system (CNS) lymphoma or leptomeningeal infiltration
Known central nervous system lymphoma.
Known central nervous system (CNS) lymphoma
Current central nervous system (CNS) lymphoma or leptomeningeal infiltration.
Known central nervous system (CNS) lymphoma
Known central nervous system (CNS) lymphoma
Known central nervous system lymphoma
Known central nervous system (CNS) lymphoma
Presence of central nervous system (CNS) lymphoma
Patients with active known central nervous system (CNS) involvement of CLL or lymphoma; (patients with history of CNS CLL or lymphoma now in remission are eligible for the trial)
Diagnosis of primary central nervous system lymphoma
Prior therapy for central nervous system (CNS) lymphoma\r\n* Steroids not an exclusion
Known central nervous system (CNS) lymphoma or leukemia
Known central nervous system (CNS) lymphoma
History of central nervous system lymphoma (either primary or metastatic).
Central nervous system lymphoma, including lymphomatous meningitis
Patients with active and/or untreated central nervous system (CNS) lymphoma will not be eligible
History of central nervous system lymphoma (either primary or metastatic).
Primary central nervous system (CNS) lymphoma
Has known active central nervous system (CNS) lymphoma
Has known active central nervous system (CNS) lymphoma
Known central nervous system (CNS) lymphoma
Central nervous system (CNS) or meningeal involvement, or cord compression by the lymphoma; history of CNS lymphoma
Known central nervous system lymphoma
Central nervous system (CNS) lymphoma
Known active central nervous system lymphoma
Active central nervous system lymphoma
All patients with central nervous system lymphoma
Central nervous system (CNS) lymphoma: CNS involvement by lymphoma, including parenchymal brain or spinal cord lymphoma or known presence of leptomeningeal disease prior to registration
Patients with evidence of active central nervous system lymphoma
Known central nervous system lymphoma
Known central nervous system (CNS) lymphoma
Active central nervous system (CNS) disease defined as symptomatic meningeal lymphoma or known CNS parenchymal lymphoma; a lumbar puncture demonstrating DLBCL at the time of registration to this study is not exclusion for study enrollment
Active central nervous system lymphoma
Known active central nervous system or leptomeningeal lymphoma
Known history of, or clinically apparent, central nervous system (CNS) lymphoma or leptomeningeal lymphoma.
Primary central nervous system (CNS) lymphoma
Known central nervous system (CNS) lymphoma or leukemia
Patients should not have evidence of active central nervous system lymphoma
All patients with central nervous system lymphoma.
Lymphoma involving the central nervous system
Central nervous system (CNS) involvement by lymphoma including parenchymal brain or spinal cord lymphoma or known presence of leptomeningeal disease prior to registration
Lymphoma involving the central nervous system
Known active central nervous system or leptomeningeal lymphoma
Current or past history of central nervous system lymphoma
Patients with primary central nervous system (CNS) lymphoma
Central nervous system lymphoma or leptomeningeal infiltration
Known central nervous system lymphoma
Known active central nervous system lymphoma or leptomeningeal disease
Central nervous system lymphoma or leptomeningeal infiltration
Participants with central nervous system (CNS) lymphoma
Lymphoma involving the central nervous system
Known central nervous system lymphoma (either primary or metastatic).
Patients with active central nervous system (CNS) disease defined as symptomatic meningeal lymphoma or known CNS parenchymal lymphoma
Known central nervous system (CNS) lymphoma
Known central nervous system lymphoma or leptomeningeal disease, except subjects with a history of central nervous system lymphoma treated and in remission > 6 months
Known central nervous system (CNS) lymphoma
All patients with central nervous system lymphoma
Known central nervous system lymphoma
Known central nervous system (CNS) lymphoma
Known central nervous system lymphoma
Known central nervous system or primary mediastinal lymphoma
All patients with history of central nervous system lymphoma
Known active Central Nervous System (CNS) lymphoma.
No active central nervous system (CNS) disease defined as symptomatic meningeal lymphoma or known CNS parenchymal lymphoma; a lumbar puncture demonstrating mantle cell lymphoma at the time of registration to this study is not an exclusion for study enrollment
Primary central nervous system (CNS) lymphoma
History of central nervous system lymphoma (either primary or metastatic) or leptomeningeal disease.
Medically apparent central nervous system lymphoma or leptomeningeal disease
Central nervous system lymphoma or leptomeningeal disease
Active central nervous system (CNS) lymphoma
Known central nervous system lymphoma
History of lymphoma involving the central nervous system
Known central nervous system (CNS) lymphoma
Central nervous system (CNS) lymphoma
All patients with active central nervous system lymphoma
Clinical evidence of extra-central nervous system (CNS) (systemic) non-Hodgkin lymphoma
Central Nervous System (CNS) Lymphoma or chronic immunosuppression-associated central nervous system (CNS) lymphoma.
Medically apparent central nervous system lymphoma or leptomeningeal disease
Primary central nervous system (CNS) lymphoma
Central nervous system or leptomeningeal lymphoma
Primary central nervous system (CNS) lymphoma
Evidence of central nervous system lymphoma or lymphomatous meningitis
Patients with active central nervous system (CNS) lymphoma
Central nervous system (CNS) metastases from lymphoma or small cell lung cancer
Known central nervous system (CNS) lymphoma, leptomeningeal lymphoma
Known central nervous system lymphoma
Central nervous system (CNS) lymphoma; active brain or leptomeningeal metastases.
Diagnosis of primary central nervous system (CNS) lymphoma
Known central nervous system (CNS) lymphoma
Known central nervous system (CNS) lymphoma
Patients with central nervous system (CNS) lymphoma are not eligible for the trial unless the disease had been treated and the subject remains without symptoms with no active CNS lymphoma.
Have known central nervous system metastasis or Central Nervous System lymphoma;
History or current evidence of central nervous system lymphoma
History of primary central nervous system lymphoma or neoplastic central nervous system disease
Known central nervous system (CNS) lymphoma or leukemia
